Bioavailable Trace Metals in Neurological Diseases (Q38967236)

8 September 2017

1 reference

title

Bioavailable Trace Metals in Neurological Diseases (English)

1 reference

8 September 2017

David Devos

4

0 references

France Woimant

6

object named as

France Woimant

1 reference

8 September 2017

Aurélia Poujois

1

1 reference

8 September 2017

Jean-Christophe Devedjian

2

1 reference

8 September 2017

Caroline Moreau

3

1 reference

8 September 2017

Pascal Chaine

5

1 reference

8 September 2017

James A Duce

7

1 reference

8 September 2017

publication date

1 October 2016

1 reference

full work available at URL

8 September 2017

http://eprints.whiterose.ac.uk/105987/

content deliverer

White Rose Research Online

0 references

published in

Current treatment options in neurology

1 reference

8 September 2017

volume

18

1 reference

8 September 2017

issue

10

1 reference

8 September 2017

page(s)

46

1 reference

Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

A review of pitfalls and progress in chelation treatment of metal poisonings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Cadmium exposure: health hazards of silver cottage industry in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Lead and mercury exposures: interpretation and action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

The Toxicology of Mercury — Current Exposures and Clinical Manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Copper transport to the brain by the blood-brain barrier and blood-CSF barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Regulation of brain copper homeostasis by the brain barrier systems: effects of Fe-overload and Fe-deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Copper handling machinery of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Copper mediated neurological disorder: visions into amyotrophic lateral sclerosis, Alzheimer and Menkes disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Pathological mitochondrial copper overload in livers of Wilson's disease patients and related animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Disorders of heavy metals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

A genetic study of Wilson's disease in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Extensive striatal, cortical, and white matter brain MRI abnormalities in Wilson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Corpus callosum abnormalities in Wilson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Wilson's disease and other neurological copper disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Efficacy and safety of oral chelators in treatment of patients with Wilson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Long term results of liver transplantation for Wilson's disease: experience in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Translational research investigations on ATP7A: an important human copper ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

ATP7A gene addition to the choroid plexus results in long-term rescue of the lethal copper transport defect in a Menkes disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Inborn errors of copper metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

MEDNIK syndrome: a novel defect of copper metabolism treatable by zinc acetate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Mutations in SLC33A1 cause a lethal autosomal-recessive disorder with congenital cataracts, hearing loss, and low serum copper and ceruloplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Impact of copper deficiency in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Hematological manifestations of copper deficiency: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron overload in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron-regulatory proteins: molecular biology and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron metabolism in the CNS: implications for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

A review of iron studies in overweight and obese children and adolescents: a double burden in the young?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Regional siderosis: a new challenge for iron chelation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Targeting chelatable iron as a therapeutic modality in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Therapeutic advances in neurodegeneration with brain iron accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

A pilot trial of deferiprone for neurodegeneration with brain iron accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Increased nigral iron content in postmortem parkinsonian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

X-ray fluorescence analysis of iron and manganese distribution in primary dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

MRI assessment of basal ganglia iron deposition in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron and dopamine: a toxic couple.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron trafficking inside the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Susceptibility contrast in high field MRI of human brain as a function of tissue iron content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron Regulates Apolipoprotein E Expression and Secretion in Neurons and Astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Combined deletions of amyloid precursor protein and amyloid precursor-like protein 2 reveal different effects on mouse brain metal homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron metabolism disturbance in a French cohort of ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Inappropriately chelated iron in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Mapping of iron deposition in conjunction with assessment of nerve fiber tract integrity in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Manganese neurotoxicity and the role of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Manganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Recovery after copper-deficiency myeloneuropathy in Wilson’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-016-0426-1

Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson's disease diagnosis

21 January 2018

1 reference

12 December 2020

Manifestations of copper excess

1 reference

12 December 2020

Original Papers: ON THE OCCURRENCE OF ABNORMAL DEPOSITS OF IRON IN THE BRAIN IN PARKINSONISM WITH SPECIAL REFERENCE TO ITS LOCALISATION.

1 reference

12 December 2020

Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis

1 reference

12 December 2020

The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Overexpression of human wild-type amyloid-β protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells

1 reference

12 December 2020

The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders

1 reference

12 December 2020

Serum ferritin is elevated in amyotrophic lateral sclerosis patients.

1 reference

12 December 2020

Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease

1 reference

12 December 2020

10.1007/S11940-016-0426-1

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

0 references

1012043093

0 references

Microsoft Academic ID

2524396650

0 references

1 reference